Oxford University Hospitals NHS Foundation Trust
Oxford University Hospitals NHS Foundation Trust
Oxford, United Kingdom24 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Two-part Study to Investigate the Effects in Adults of Two Doses of Golexanolone in Patients With Primary Biliary Cholangitis (PBC) With Fatigue and Cognitive Dysfunction | Digestive System Diseases, Fatigue, Fibrosis, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, bile duct disorder, biliary tract disorder, cholestasis, cirrhosis of liver, intrahepatic cholestasis, liver disorder, primary biliary cholangitis | Active, not recruiting | Phase 1 / Phase 2 | 2026-10-08 | NCT07304843 | |
| A Non-interventional Study of Participants With BPDCN Treated With Chemotherapy | CD4+/CD56+ hematodermic neoplasm, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, Neoplasms by Site, Skin and Connective Tissue Diseases, hematologic disorder, hematopoietic and lymphoid system neoplasm, leukemia, lymphoma, malignant histiocytosis, neoplasm, skin disorder, skin neoplasm | Recruiting | Not stated | 2026-09-15 | NCT07785180 | |
| Osteogenesis Imperfecta Trial of AGA2115 for ADUlts With COL1A1 and/or COL1A2 GeNetic Variations (IDUN) | Bone Diseases, Developmental, Collagen Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Skin and Connective Tissue Diseases, bone disorder, connective tissue disorder, hereditary disease, musculoskeletal system disorder, osteochondrodysplasia, osteogenesis imperfecta | Recruiting | Phase 2 | 2026-08-17 | NCT07062588 | |
| Study to Assess GTAEXS617 in Participants With Advanced Solid Tumors | Adnexal Diseases, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Head and Neck Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Skin and Connective Tissue Diseases, Thoracic Neoplasms, Urogenital Diseases, Urogenital Neoplasms, breast disorder, breast neoplasm, bronchial neoplasm, bronchogenic carcinoma, carcinoma, epithelial neoplasm, fallopian tube disorder, fallopian tube neoplasm, female reproductive system disorder, female reproductive system neoplasm, head and neck squamous cell carcinoma, lung disorder, lung neoplasm, neoplasm, non-small cell lung carcinoma, pancreatic adenocarcinoma, respiratory system disorder, respiratory tract neoplasm, skin disorder, squamous cell carcinoma, triple-negative breast carcinoma | Recruiting | Phase 1 / Phase 2 | 2026-08-13 | NCT05985655 | |
| The Oxford Risk Factors And Non-Invasive Imaging Study | cardiovascular disorder | Recruiting | Not stated | 2026-07-31 | NCT05169333 | |
| Placental Biology in Health and Disease | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Female Urogenital Diseases and Pregnancy Complications, Fetal Diseases, Nutritional and Metabolic Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Urogenital Diseases, cardiovascular disorder, diabetes mellitus, endocrine system disorder, fetal growth restriction, gestational diabetes, glucose metabolism disease, hereditary endocrine growth disease, hypertension, pregnancy-induced, hypertensive disorder, metabolic disease, preeclampsia, pregnancy disorder, vascular disorder | Recruiting | Not stated | 2026-07-23 | NCT07470320 | |
| Treatment of Retinal Detachment in People Who Have Not Had Cataract Surgery With Vitrectomy vs Vitrectomy and Cataract Removal | cataract, eye disorder, lens disorder, rhegmatogenous retinal detachment | Recruiting | Phase 3 | 2026-06-10 | NCT06997874 | |
| A Prospective Randomised Study of Treatment Selection Based on Epigenetic Markers Versus Standard of Care Treatment Selection in Adults With CROHN's Disease | Crohn disease, Digestive System Diseases, digestive system disorder, gastroenteritis, inflammatory bowel disease, intestinal disorder | Recruiting | Not applicable | 2026-06-01 | NCT07363044 | |
| IVIG and Rituximab in Antibody-associated Psychosis - SINAPPS2 | Psychotic Disorders, Schizophrenia Spectrum and Other Psychotic Disorders, autoimmune disease, autoimmune disorder of the nervous system, autoimmune encephalitis, immune system disorder, nervous system disorder, psychiatric disorder | Active, not recruiting | Phase 2 | 2026-05-22 | NCT03194815 | |
| Anti-tumour Activity of (177Lu) rhPSMA-10.1 Injection | Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Male Urogenital Diseases, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, male reproductive organ cancer, male reproductive system disorder, neoplasm, prostate cancer, prostate disorder | Recruiting | Phase 1 / Phase 2 | 2026-05-14 | NCT05413850 | |
| Relapsed Follicular Lymphoma Randomised Trial Against Standard ChemoTherapy | Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, follicular lymphoma, immune system disorder, immunoproliferative disorder, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, neoplasm | Recruiting | Phase 2 | 2026-05-05 | NCT05848765 | |
| Defining the Genetics, Biomarkers and Outcomes for Dilated Cardiomyopathy | Cardiomegaly, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, cardiomyopathy, cardiovascular disorder, dilated cardiomyopathy, heart disorder, hereditary disease, laminopathy | Active, not recruiting | Not stated | 2026-03-27 | NCT03843255 | |
| Closed-loop for People Living With Cystic Fibrosis Related Diabetes | cystic fibrosis-related diabetes | Active, not recruiting | Not applicable | 2026-02-20 | NCT05562492 | |
| Oxford Pleural Embolisation Trial | Neoplasms by Site, Thoracic Neoplasms, lung cancer, lung disorder, lung neoplasm, neoplasm, respiratory system disorder, respiratory tract neoplasm | Recruiting | Not applicable | 2026-02-04 | NCT06651658 | |
| Statins for Venous Event Reduction in Patients With Venous Thromboembolism | Embolism and Thrombosis, Postthrombotic Syndrome, Thromboembolism, Venous Thrombosis, cardiovascular disorder, thrombotic disease, vascular disorder, venous insufficiency, venous thromboembolism | Recruiting | Phase 3 | 2026-01-15 | NCT04319627 | |
| Long-Term Follow-Up of TX200-TR101 (STEADFAST Long Term) | Chronic Disease, Disease Attributes, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Urogenital Diseases, chronic renal failure syndrome, kidney disorder, kidney failure, urinary system disorder | Active, not recruiting | Not stated | 2025-12-04 | NCT05987527 | |
| Phase 1b/II Trial of Pembrolizumab Plus IMRT in Stage III/IV Carcinoma of Anus | Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, anus disorder, anus neoplasm, colorectal neoplasm, digestive system disorder, digestive system neoplasm, intestinal disorder, neoplasm, rectal disorder, rectal neoplasm | Active, not recruiting | Phase 1 | 2025-08-05 | NCT04046133 | |
| Romiplostim Plus Dexamethasone vs Dexamethasone in Patients With Newly Diagnosed Primary Immune Thrombocytopenia | Cytopenia, Hemic and Lymphatic Diseases, Hemorrhage, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Purpura, Thrombocytopenic, Idiopathic, Signs and Symptoms, Skin Manifestations, autoimmune disease, blood coagulation disease, blood platelet disease, hematologic disorder, hemorrhagic disease, immune system disorder, purpura, thrombocytopenia, thrombocytopenic purpura, thrombotic microangiopathy | Active, not recruiting | Phase 3 | 2025-06-17 | NCT05325593 | |
| The Dragon PLC Trial (DRAGON-PLC) | Digestive System Diseases, Digestive System Neoplasms, Liver Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, adenocarcinoma, carcinoma, cholangiocarcinoma, epithelial neoplasm, hepatocellular carcinoma, liver cancer, liver disorder, neoplasm | Recruiting | Not applicable | 2025-05-15 | NCT06914648 | |
| DOLCE: Determining the Impact of Optellum's Lung Cancer Prediction Solution | Multiple Pulmonary Nodules, Neoplasms by Site, Thoracic Neoplasms, lung cancer, lung disorder, lung neoplasm, neoplasm, pulmonary coin lesion, respiratory system disorder, respiratory tract neoplasm | Recruiting | Not stated | 2025-04-08 | NCT05389774 | |
| First-in-human Study of OVM-200 as a Therapeutic Cancer Vaccine | Adnexal Diseases, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Male Urogenital Diseases, Neoplasms by Site, Thoracic Neoplasms, Urogenital Diseases, Urogenital Neoplasms, bronchial neoplasm, bronchogenic carcinoma, endocrine system disorder, female reproductive system disorder, female reproductive system neoplasm, gonadal disorder, lung disorder, lung neoplasm, male reproductive organ cancer, male reproductive system disorder, malignant endocrine neoplasm, neoplasm, non-small cell lung carcinoma, ovarian cancer, ovarian disorder, prostate cancer, prostate disorder, respiratory system disorder, respiratory tract neoplasm | Recruiting | Phase 1 | 2025-02-14 | NCT05104515 | |
| Supported Rescue Packs Post-discharge in Chronic Obstructive Pulmonary Disease | Chronic Disease, Disease Attributes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, chronic obstructive pulmonary disease, lung disorder, obstructive lung disease, respiratory system disorder | Recruiting | Phase 3 | 2025-02-10 | NCT06347536 | |
| ICONIC: Improving Outcomes Through Collaboration in OsteosarComa | Neoplasms by Histologic Type, Neoplasms, Bone Tissue, Neoplasms, Connective and Soft Tissue, connective tissue neoplasm, neoplasm, osteosarcoma, sarcoma | Recruiting | Not stated | 2024-08-02 | NCT04132895 | |
| The European NAFLD Registry | Body Weight, Digestive System Diseases, Digestive System Neoplasms, Dyslipidemias, Fibrosis, Fibrosis, Liver, Lipid Metabolism Disorders, Liver Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Nutritional and Metabolic Diseases, Overweight, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Steatohepatitis, adenocarcinoma, carcinoma, cardiovascular disorder, cirrhosis of liver, diabetes mellitus, endocrine system disorder, epithelial neoplasm, fatty liver disease, glucose metabolism disease, hepatocellular carcinoma, hypertensive disorder, liver disorder, metabolic disease, metabolic dysfunction-associated steatohepatitis, metabolic dysfunction-associated steatotic liver disease, neoplasm, nutritional disorder, obesity disorder, overnutrition, type 2 diabetes mellitus, vascular disorder | Recruiting | Not stated | 2023-01-06 | NCT04442334 |